TORONTO, Jan. 11, 2018 /CNW/ - Nuuvera Inc.
("Nuuvera") (TSXV: NUU) and Aphria Inc. ("Aphria") (TSX: APH &
US OTC QB: APHQF) announced today that they are in negotiations
regarding an offtake agreement.
On January 8, 2018, Aphria
announced that it had entered into a strategic relationship with
Double Diamond Farms to provide Aphria with 120,000 kgs of annual
cannabis production. Nuuvera announced today that it is in
negotiations with Aphria regarding an offtake agreement for 60,000
kgs of such cannabis production which is expected to be available
for sale in January 2019, pending
Health Canada approvals. Further details will be provided upon the
parties entering into a definitive agreement. There can be no
assurance that a definitive offtake agreement will be executed.
For more information, please visit: www.nuuvera.com
About Nuuvera
Nuuvera is a global cannabis company founded on Canadian
principles, and built with the whole world in mind. Nuuvera is
currently working with partners in Germany, Israel and Italy, and is exploring opportunities in
several other countries, to develop commercial production and
global distribution of medical grade cannabis in legalized markets.
Through its subsidiaries, ARA – Avanti Rx Analytics Inc. and Avalon
Pharmaceutical Inc., Nuuvera holds a Dealer License (GMP) under the
Narcotic Control Regulations and Office of Controlled Substances.
Nuuvera is currently in the final stages of the Health Canada
review process to become a Licensed Producer of medical marijuana
under the ACMPR, and has recently received its "letter to build"
approval.
About Aphria
Aphria Inc., one of Canada's lowest cost producers, produces,
supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of
Canada. Aphria is truly powered by sunlight, allowing for the
most natural growing conditions available. We are committed
to providing pharma-grade medical cannabis, superior patient care
while balancing patient economics and returns to shareholders.
For more information, visit
www.Aphria.com.
Notice regarding forward-looking statements:
This release includes forward-looking statements regarding
Nuuvera and its business. Often, but not always, forward-looking
statements can be identified by the use of words such as "plans",
"is expected", "expects", "scheduled", "intends", "contemplates",
"anticipates", "believes", "proposes" or variations (including
negative variations) of such words and phrases, or state that
certain actions, events or results "may", "could", "would", "might"
or "will" be taken, occur or be achieved. Such statements are based
on the current expectations of the management of Nuuvera. The
forward-looking events and circumstances discussed in this release
may not occur by certain specified dates or at all and could differ
materially as a result of known and unknown risk factors and
uncertainties affecting Nuuvera, including risks regarding the
cannabis industry, failure to obtain regulatory approvals, economic
factors, the equity markets generally and risks associated with
growth and competition. Although Nuuvera has attempted to identify
important factors that could cause actual actions, events or
results to differ materially from those described in
forward-looking statements, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. No forward-looking statement can be
guaranteed. Except as required by applicable securities laws,
forward-looking statements speak only as of the date on which they
are made Nuuvera undertakes no obligation to publicly update or
revise any forward-looking statement, whether as a result of new
information, future events, or otherwise.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Nuuvera Inc.